Suspension of trading
Comparison Chart Repare Therapeutics Inc.
Stocks
RPTX
US7602731025
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.650 USD | +0.76% |
|
-.--% | +1.92% |
| 02-03 | Pyxis Oncology, Inc. Announces Chief Executive Officer Changes, Effective February 3, 2026 | CI |
| 01-27 | Repare Therapeutics Inc.(NasdaqGS:RPTX) dropped from NASDAQ Composite Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REPARE THERAPEUTICS INC. | Other Biotechnology & Medical Research | +0.76% | -.--% | +1.92% | +73.20% | -92.03% | 114M |
-
|
-
|
-
|
- Stock Market
- Stocks
- RPTX Stock
- Charts Repare Therapeutics Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
